303 related articles for article (PubMed ID: 19406232)
1. In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets.
Shoukri RA; Ahmed IS; Shamma RN
Eur J Pharm Biopharm; 2009 Sep; 73(1):162-71. PubMed ID: 19406232
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin.
Ahmed IS; Aboul-Einien MH
Eur J Pharm Sci; 2007 Sep; 32(1):58-68. PubMed ID: 17628451
[TBL] [Abstract][Full Text] [Related]
3. Development and optimization of lyophilized orally disintegrating tablets using factorial design.
Ahmed IS; Shamma RN; Shoukri RA
Pharm Dev Technol; 2013; 18(4):935-43. PubMed ID: 22107175
[TBL] [Abstract][Full Text] [Related]
4. Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: a single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states.
Ahmed IS; Aboul-Einien MH; Mohamed OH; Farid SF
Eur J Pharm Sci; 2008 Oct; 35(3):219-25. PubMed ID: 18675344
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study.
Chen L; Jiang X; Huang L; Lan K; Wang H; Hu L; Ren J; Li X; Zou Q
Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895
[TBL] [Abstract][Full Text] [Related]
6. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic profile of rizatriptan 10-mg tablet and 10-mg orally disintegrating tablet administered with or without water in healthy subjects: an open-label, randomized, single-dose, 3-period crossover study.
Swan SK; Alcorn H; Rodgers A; Hustad CM; Ramsey KE; Woll S; Skobieranda F
J Clin Pharmacol; 2006 Feb; 46(2):172-8. PubMed ID: 16432269
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
[TBL] [Abstract][Full Text] [Related]
11. Absence of food effect on the extent of alprazolam absorption from an orally disintegrating tablet.
Erdman K; Stypinski D; Combs M; Witt P; Stiles M; Pollock S
Pharmacotherapy; 2007 Aug; 27(8):1120-4. PubMed ID: 17655512
[TBL] [Abstract][Full Text] [Related]
12. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic comparison of orally-disintegrating metoclopramide with conventional metoclopramide tablet formulation in healthy volunteers.
Fass R; Pieniaszek HJ; Thompson JR
Aliment Pharmacol Ther; 2009 Aug; 30(3):301-6. PubMed ID: 19459829
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of the disintegration of orally rapid disintegrating tablets by X-ray computed tomography.
Otsuka M; Yamanaka A; Uchino T; Otsuka K; Sadamoto K; Ohshima H
Chem Pharm Bull (Tokyo); 2012; 60(12):1502-7. PubMed ID: 23006519
[TBL] [Abstract][Full Text] [Related]
15. Development of sildenafil-loaded orally disintegrating tablet with new lactate salt.
Jung SY; Kim DW; Seo YG; Woo JS; Yong CS; Choi HG
Drug Dev Ind Pharm; 2012 May; 38(5):635-41. PubMed ID: 22010981
[TBL] [Abstract][Full Text] [Related]
16. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG
Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
Sano S; Iwao Y; Kimura S; Itai S
Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
19. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
Henney HR; Shah J
Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
[TBL] [Abstract][Full Text] [Related]
20. A pilot human pharmacokinetic study and influence of formulation factors on orodispersible tablet incorporating meloxicam solid dispersion using factorial design.
Aboelwafa AA; Fahmy RH
Pharm Dev Technol; 2012; 17(1):1-14. PubMed ID: 20550483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
